Curiox Biosystems Revenue and Competitors

Location

$15M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Curiox Biosystems's estimated annual revenue is currently $4.9M per year.(i)
  • Curiox Biosystems's estimated revenue per employee is $77,500
  • Curiox Biosystems's total funding is $15M.

Employee Data

  • Curiox Biosystems has 63 Employees.(i)
  • Curiox Biosystems grew their employee count by -24% last year.

Curiox Biosystems's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
EVP, CFOReveal Email/Phone
3
Director Product and Scientific AffairsReveal Email/Phone
4
Accounting and Sales SpecialistReveal Email/Phone
5
Associate Director Sales- EuropeReveal Email/Phone
6
Field Application ScientistReveal Email/Phone
7
Marketing AssociateReveal Email/Phone
8
Field Application ScientistReveal Email/Phone
9
Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.9M63-24%$15MN/A
#2
$20M129-16%$150MN/A
#3
$3.7M48-6%$53MN/A
#4
$5.4M35-8%N/AN/A
#5
$3.6M23-18%N/AN/A
#6
$3.4M220%N/AN/A
#7
$5.4M356%N/AN/A
#8
$7.1M46-26%N/AN/A
#9
$36.1M2334%N/AN/A
#10
$3.1M20-61%N/AN/A
Add Company

What Is Curiox Biosystems?

Faster and automatable, Laminar Washâ„¢ systems deliver higher quality data through better cell retention, better preservation of cellular physiology and viability, and improved study-to-study and operator-to-operator reproducibility.

keywords:N/A

$15M

Total Funding

63

Number of Employees

$4.9M

Revenue (est)

-24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Curiox Biosystems News

2022-03-22 - Curiox Biosystems Closes $15M Series C Funding Round

Curiox Biosystems, Inc., a Woburn, Mass.-based leader in biological sample preparation automation, closed a $15m Series C financing round.

2022-03-22 - Curiox Biosystems Closes $15 million Funding Round to ...

About Curiox Biosystems, Inc. Next-generation therapies deserve next-generation sample prep solutions. Curiox has brought together surface...

2019-10-18 - Singapore: Zig Ventures-backed Curiox raises $15m, eyes Korea IPO

Premium Curiox Biosystems, a bio-instrumentation company backed by Singapore-based venture investment firm Zig Ventures, has raised $15 million in its Series B funding round that it will use for global commercialisation activities. Continue reading this story with a subscription to DealStreetA ...

2019-10-16 - Curiox Biosystems Secures US$15M in Series B Funding

Curiox Biosystems, a Singapore-based developer of bioinstrumentation solutions used in cell analysis and therapy for the pharmaceutical and biotech industries, secured a Series B funding of US$15M. Backers included KB Investment, IMM Investment, QUAD Investment, HB Investment, DAYLI Investment, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.8M63-7%N/A
#2
$8.4M64N/AN/A
#3
$12.9M645%N/A
#4
$11.9M65N/AN/A
#5
$19.2M65-16%N/A